secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eledon Pharmaceuticals, Inc. (ELDN)
CIK:        0001404281
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0000950170-24-118497
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eledon Pharmaceuticals prices $85M offering of common stock and pre-funded warrants at $3.65/share
--------------------------------------------------------------------------------

- Gross proceeds ~$85M; net proceeds ~$79.5M after underwriting discounts and expenses.
- Offering: 18,356,173 common shares at $3.65 plus pre-funded warrants for 4,931,507 shares at $3.649.
- Investors include BVF Partners, RA Capital, Frazier Life Sciences, Blue Owl, First Light, Sphera, Woodline, Nantahala, and T1D Fund.
- Proceeds to be used for advancing pipeline, working capital, and general corporate purposes.
- Closing expected on or about October 30, 2024; 90-day lock-up for executives and directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404281/000095017024118497/0000950170-24-118497-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404281/000095017024118497/eldn-20241029.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-118497

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer